Abstract:Background & aims: Kidney dysfunction is a major determinant of prognosis in patients with decompensated cirrhosis awaiting transplantation. We hypothesized that for identical MELD scores at listing, outcomes before and after liver transplantation may vary if the predominant driver of the MELD score is serum creatinine versus serum bilirubin or INR. Methods: We evaluated all adult patients registered for liver transplantation (LT) between 2016 - 2020 and excluded patients receiving MELD exceptions or undergoing dual organ transplantation. Using K-Means clustering analysis, we classified each patient as MELD-Br, MELD-INR or MELD-Cr depending on the dominant variable for their MELD score. The primary outcome was intent-to-treat survival, defined as survival within 1 year from listing with or without LT. Results: MELD scores of LT waitlist registrants clustered into 3 subtypes: MELD-Br (n=13,658), MELD-INR (n=13,809), and MELD-Cr (n=12,412). One-year ITT survival was 78% (MELD-Br), 75% (MELD-INR), and 65% (MELD-Cr), p<0.01. ITT survival was lower for each MELD subtype for females compared to males (e.g. MELD Cr 63% females vs 67% males, p<0.0001). MELD-Cr subtype had the highest MELD at listing (MELD Cr 23.4 vs MELD-Br 19.2 vs MELD INR 21.0) and the largest decline in MELD over 3 months (23% vs. 12% vs 21%). In adjusted analyses including MELD Na, MELD-Cr compared to the other subtypes was associated with higher WL mortality (HR 1.339, 95% CI 1.279-1.402) and lower LT rates (HR 0.688, 95% CI 0.664-0.713). Conclusions: For equivalent listing practices, registrants with MELD-Cr subtype have lower ITT survival. MELD subtype may serve as a more sophisticated variable for dynamic assessment of risk of mortality, to inform models for organ allocation. Impact and implications: The MELD score is an excellent predictor of waitlist mortality; however, our work highlights that the driver of a patient's score MELD score matters and particularly those driven by elevated creatinine have a lower 1-year ITT mortality. The 1-year ITT mortality is also lower for women compared to men within the Cr-dominant subtype. These results are important for physicians and patients undergoing LT evaluation as creatinine may serve as a marker of prognosis and even if the creatinine improves the prognosis remains poor, necessitating discussion about alternative pathways for transplant. Our work also highlights that the type of kidney injury matters, in that those AKI were more likely to die or remain on the waitlist compared to those with CKD within the creatinine dominant subtype.

Revising model for end-stage liver disease from calendar-time cross-sections with correction for selection bias

Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients with Plasma Exchange Treatment.

Evaluation und Notwendigkeit einer Anpassung des MELD Scores in der Eurotransplantregion

Variant Outcomes of Liver Transplantation for Hepatitis C Virus Patients in Different Age Categories: Impact of the Model for End-Stage Liver Disease Score

Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation

Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients

Variation in intention-to-treat survival by MELD subtypes: all models created for end-stage liver disease are not equal

Survival Tree and Meld to Predict Long Term Survival in Liver Transplantation Waiting List

Evidence-based Incorporation of Key Parameters into MELD Score for Acute-on-chronic Liver Failure

The Evolution of the MELD Score and Its Implications in Liver Transplant Allocation: A Beginner's Guide for Trainees

Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design

Machine Learning for Post-Liver Transplant Survival: Bridging the Gap for Long-term Outcomes through Temporal Variation Features

Differences in Access to Liver Transplantation: Disease Severity, Waiting Time, and Transplantation Center Volume

Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry

Multinational Analysis of Marginal Liver Grafts Based on the Eurotransplant Extended Donor Criteria

A brief model evaluated outcomes after liver transplantation based on the matching of donor graft and recipient

Expanding MELD exceptions for colorectal liver metastasis: data and policy

Performance of risk prediction models for post-liver transplant patient and graft survival over time

[Review of Risk Evaluation Scores for Benign End Stage Liver Diseases Recipients].

Downgrading Meld Improves the Outcomes after Liver Transplantation in Patients with Acute-On-Chronic Hepatitis B Liver Failure

Therapeutic Evaluation of the Patients with High MELD Scores Undergoing Liver Transplantation for Benign End-Stage Liver Disease